Crown Bioscience International's Pending Acquisition

Crown Bioscience International raised a round of funding on December 20, 2017. Investors include JSR.

Crown Bioscience International is a drug discovery and development service company providing translational platforms and drug discovery solutions for its biotech and pharmaceutical partners in dedicat…

Articles about Crown Bioscience International's Pending Acquisition: